IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?

被引:2
作者
Cui, Xiaoyu [1 ,2 ]
Liu, Wu [1 ]
Jiang, Hanxue [1 ]
Zhao, Qihan [1 ,2 ]
Hu, Yuehong [1 ,2 ]
Tang, Xinyue [1 ,2 ]
Liu, Xianli
Dai, Haoran [1 ,4 ]
Rui, Hongliang [1 ,3 ]
Liu, Baoli [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing 100010, Peoples R China
[2] Capital Med Univ, Lab Clin Med, Beijing 100069, Peoples R China
[3] Beijing Inst Chinese Med, Beijing 100010, Peoples R China
[4] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Shunyi Branch, Beijing 100310, Peoples R China
基金
中国国家自然科学基金;
关键词
Autoimmune diseases; Cytokine; IL-12; IL-23; IL-35; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVE PSORIATIC-ARTHRITIS; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; COLLAGEN-INDUCED ARTHRITIS; STIMULATORY FACTOR NKSF; BIOLOGIC-NAIVE PATIENTS; DOUBLE-BLIND; B-CELL;
D O I
10.1016/j.jtauto.2024.100263
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In recent years, the discovery of IL-12 family cytokines, which includes IL-12, IL-23, IL-27, IL-35, and IL-39, whose biological functions directly or indirectly affect various autoimmune diseases. In autoimmune diseases, IL-12 family cytokines are aberrantly expressed to varying degrees. These cytokines utilize shared subunits to influence T-cell activation and differentiation, thereby regulating the balance of T-cell subsets, which profoundly impacts the onset and progression of autoimmune diseases. In such conditions, IL-12 family members are aberrantly expressed to varying degrees. By exploring their immunomodulatory functions, researchers have identified varying therapeutic potentials for each member. This review examines the physiological functions of the major IL-12 family members and their interactions, discusses their roles in several autoimmune diseases, and summarizes the progress of clinical studies involving monoclonal antibodies targeting IL-12 and IL-23 subunits currently available for treatment.
引用
收藏
页数:20
相关论文
共 227 条
[91]   Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes [J].
Li, Y. ;
Li, D. ;
Li, Y. ;
Wu, S. ;
Jiang, S. ;
Lin, T. ;
Xia, L. ;
Shen, H. ;
Lu, J. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (04) :1537-1546
[92]   Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity [J].
Li, Yuxuan ;
Yao, Lutian ;
Liu, Siyan ;
Wu, Jisheng ;
Xia, Liping ;
Shen, Hui ;
Lu, Jing .
JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (03) :707-710
[93]   Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway [J].
Liang, Yanfang ;
Chen, Qianqian ;
Du, Wenjing ;
Chen, Can ;
Li, Feifei ;
Yang, Jingying ;
Peng, Jianyu ;
Kang, Dongping ;
Lin, Bihua ;
Chai, Xingxing ;
Zhou, Keyuan ;
Zeng, Jincheng .
MEDIATORS OF INFLAMMATION, 2016, 2016
[94]   Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis [J].
Linke, Alexandra ;
Tiegs, Gisa ;
Neumann, Katrin .
CELLS, 2022, 11 (10)
[95]   Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role [J].
Liu, Wenbin ;
Gao, Chang ;
Dai, Haoran ;
Zheng, Yang ;
Dong, Zhaocheng ;
Gao, Yu ;
Liu, Fei ;
Zhang, Zihan ;
Liu, Zhiyuan ;
Liu, Weijing ;
Liu, Baoli ;
Liu, Qingquan ;
Shi, Jialan .
FRONTIERS IN IMMUNOLOGY, 2019, 10 :1809
[96]   The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity [J].
Liu, Zhanju ;
Yadav, Praveen K. ;
Xu, Xiaorong ;
Su, Jingling ;
Chen, Chi ;
Tang, Maochun ;
Lin, Hui ;
Yu, Jifeng ;
Qian, Jiaming ;
Yang, Ping-Chang ;
Wang, Xingpeng .
JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 89 (04) :597-606
[97]   Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial [J].
Loesche, Michael A. ;
Farahi, Kamyar ;
Capone, Kimberly ;
Fakharzadeh, Steven ;
Blauvelt, Andrew ;
Duffin, Kristina Callis ;
DePrimo, Samuel E. ;
Munoz-Elias, Ernesto J. ;
Brodmerkel, Carrie ;
Dasgupta, Bidisha ;
Chevrier, Marc ;
Smith, Kevin ;
Horwinski, Joseph ;
Tyldsley, Amanda ;
Grice, Elizabeth A. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (09) :1973-1981
[98]   Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway [J].
Lopez-Isac, Elena ;
Campillo-Davo, Diana ;
Bossini-Castillo, Lara ;
Guerra, Sandra G. ;
Assassi, Shervin ;
Pilar Simeon, Carmen ;
Carreira, Patricia ;
Ortego-Centeno, Norberto ;
Garcia de la Pena, Paloma ;
Beretta, Lorenzo ;
Santaniello, Alessandro ;
Bellocchi, Chiara ;
Lunardi, Claudio ;
Moroncini, Gianluca ;
Gabrielli, Armando ;
Riemekasten, Gabriela ;
Witte, Torsten ;
Hunzelmann, Nicolas ;
Kreuter, Alexander ;
Distler, Jorg H. W. ;
Voskuyl, Alexandre E. ;
de Vries-Bouwstra, Jeska ;
Herrick, Ariane ;
Worthington, Jane ;
Denton, Christopher P. ;
Fonseca, Carmen ;
Radstake, Timothy R. D. J. ;
Mayes, Maureen D. ;
Martin, Javier .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (08) :1521-1526
[99]   The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12 [J].
Lupardus, Patrick J. ;
Garcia, K. Christopher .
JOURNAL OF MOLECULAR BIOLOGY, 2008, 382 (04) :931-941
[100]   Ebi3 promotes T- and B-cell division and differentiation via STAT3 [J].
Ma, Ning ;
Fang, Ying ;
Xu, Ruonan ;
Zhai, Bing ;
Hou, Chunmei ;
Wang, Xiaoqian ;
Jiang, Zhenyu ;
Wang, Liang ;
Liu, Qilin ;
Han, Gencheng ;
Wang, Renxi .
MOLECULAR IMMUNOLOGY, 2019, 107 :61-70